High-osmolarity saline in neurocritical care: Systematic review and meta-analysis

Critical Care Medicine

Volumn 41, Issue 5, 2013, Pages 1353-1360

  Lazaridis, Christos ^a   Neyens, Ron ^a,b   Bodle, Jeffrey ^a   Desantis, Stacia M ^c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

cerebral blood flow; cerebral edema; hypertonic saline; intracranial pressure; mannitol; subarachnoid hemorrhage; traumatic brain injury

Indexed keywords

MANNITOL; SODIUM CHLORIDE;

ARTICLE; BRAIN BLOOD FLOW; BRAIN EDEMA; BRAIN ISCHEMIA; COST BENEFIT ANALYSIS; CRITICALLY ILL PATIENT; DATA BASE; HUMAN; HYPERTENSION; INTENSIVE CARE; INTRACRANIAL PRESSURE; MEDICAL INFORMATION; META ANALYSIS (TOPIC); OSMOLARITY; PRIORITY JOURNAL; RESUSCITATION; SUBARACHNOID HEMORRHAGE; SYSTEMATIC REVIEW; TRAUMATIC BRAIN INJURY;

BRAIN EDEMA; BRAIN INJURIES; CRITICAL CARE; CRITICAL ILLNESS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; MALE; MANNITOL; RISK ASSESSMENT; SALINE SOLUTION, HYPERTONIC; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84876589891     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31827ca4b3     Document Type: Article

References (47)

1. Helmy A, Vizcaychipi M, Gupta AK: Traumatic brain injury: Intensive care management. Br J Anaesth 2007; 99:32-42
2. Bratton SL, Chestnut RM, Ghajar J et al: Guidelines for the management of severe traumatic brain injury. II. Hyperosmolar therapy. J Neu-rotrauma. 2007; 24 (Suppl 1):S14-S20
3. Morgenstern LB, Hemphill JC 3rd, Anderson C, et al; American Heart Association Stroke Council and Council on Cardiovascular Nursing: Guidelines for the management of spontaneous intracerebral hemorrhage: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2010; 41:2108-2129
4. Bederson JB, Connolly ES Jr, Batjer HH, et al; American Heart Association: Guidelines for the management of aneurysmal subarachnoid hemorrhage: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 2009; 40:994-1025
5. Harold P, Adams J, Zoppo GD, et al: Guidelines for the early management of adults with ischemic stroke. Stroke 2007; 38:1655-711
6. Bhardwaj A: Osmotherapy in neurocritical care. Curr Neurol Neuro-sci Rep 2007; 7:513-521
7. Wakai A, Roberts I, Schierhout G: Mannitol for acute traumatic brain injury. Cochrane Database Syst Rev 2007; CD0010
8. Hays AN, Lazaridis C, Neyens R, et al: Osmotherapy: Use among neurointensivists. Neurocrit Care 2011; 14:222-228
9. Tyagi R, Donaldson K, Loftus CM, et al: Hypertonic saline: A clinical review. Neurosurg Rev 2007; 30:277-289
10. Hauer EM, Stark D, Staykov D, et al: Early continuous hypertonic saline infusion in patients with severe cerebrovascular disease. Crit Care Med 2011; 39:1766-1772
11. Vialet R, Albanèse J, Thomachot L, et al: Isovolume hypertonic solutes (sodium chloride or mannitol) in the treatment of refractory posttrau-matic intracranial hypertension: 2 mL/kg 7.5% saline is more effective than 2 mL/kg 20% mannitol. Crit Care Med 2003; 31:1683-1687
12. Koenig MA, Bryan M, Lewin JL 3rd, et al: Reversal of transtentorial herniation with hypertonic saline. Neurology 2008; 70:1023-1029
13. Kamel H, Navi BB, Nakagawa K, et al: Hypertonic saline versus man-nitol for the treatment of elevated intracranial pressure: A meta-analy-sis of randomized clinical trials. Crit Care Med 2011; 39:554-559
14. Mortazavi MM, Romeo AK, Deep A, et al: Hypertonic saline for treating raised intracranial pressure: Literature review with meta-analysis. J Neurosurg 2012; 116:210-221
15. Casella G, Berger RL: The delta method. In: Statistical Inference. Second Edition. Crockett C, Reitz C (Eds). Pacifc Grove, CA, Duxbury, 2002, p 240
16. Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Software 2010; 36(3):1-48
17. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 1986; 7:177-188
18. Suarez JI, Qureshi AI, Bhardwaj A, et al: Treatment of refractory intracranial hypertension with 23.4% saline. Crit Care Med 1998; 26:1118-1122
19. Tseng MY, Al-Rawi PG, Pickard JD, et al: Effect of hypertonic saline on cerebral blood fow in poor-grade patients with subarachnoid hemorrhage. Stroke 2003; 34:1389-1396
20. Al-Rawi PG, Zygun D, Tseng MY, et al: Cerebral blood fow augmentation in patients with severe subarachnoid haemorrhage. Acta Neu-rochir Suppl 2005; 95:123-127
21. Al-Rawi PG, Tseng MY, Richards HK, et al: Hypertonic saline in patients with poor-grade subarachnoid hemorrhage improves cerebral blood fow, brain tissue oxygen, and pH. Stroke 2010; 41:122-128
22. Tseng MY, Al-Rawi PG, Czosnyka M, et al: Enhancement of cerebral blood fow using systemic hypertonic saline therapy improves outcome in patients with poor-grade spontaneous subarachnoid hemorrhage. J Neurosurg 2007; 107:274-282
23. Ware ML, Nemani VM, Meeker M, et al: Effects of 23.4% sodium chloride solution in reducing intracranial pressure in patients with traumatic brain injury: A preliminary study. Neurosurgery 2005; 57:727-736
24. Rockswold GL, Solid CA, Paredes-Andrade E, et al: Hypertonic saline and its effect on intracranial pressure, cerebral perfusion pressure, and brain tissue oxygen. Neurosurgery 2009; 65:1035-1041
25. Kerwin AJ, Schinco MA, Tepas JJ 3rd, et al: The use of 23.4% hyper-tonic saline for the management of elevated intracranial pressure in patients with severe traumatic brain injury: A pilot study. J Trauma 2009; 67:277-282
26. Paredes-Andrade E, Solid CA, Rockswold SB, et al: Hypertonic saline reduces intracranial hypertension in the presence of high serum and cerebrospinal fuid osmolalities. Neurocrit Care 2012; 17:204-210
27. Diringer MN, Scalfani MT, Zazulia AR, et al: Cerebral hemodynamic and metabolic effects of equi-osmolar doses mannitol and 23.4% saline in patients with edema following large ischemic stroke. Neurocrit Care 2011; 14:11-17
28. Qureshi AI, Suarez JI: More evidence supporting a "brain code" protocol for reversal of transtentorial herniation. Neurology 2008; 70:990-991
29. Weed LD, McKibben PS. Experimental alteration of brain bulk. Am J Physiol 1919; 48:531-58
30. Ziai WC, Toung TJ, Bhardwaj A: Hypertonic saline: First-line therapy for cerebral edema? J Neurol Sci 2007; 261:157-166
31. Videen TO, Zazulia AR, Manno EM, et al: Mannitol bolus preferentially shrinks non-infarcted brain in patients with ischemic stroke. Neurology 2001; 57:2120-2122
32. Bacher A, Wei J, Grafe MR, et al: Serial determinations of cerebral water content by magnetic resonance imaging after an infusion of hypertonic saline. Crit Care Med 1998; 26:108-114
33. Wisner DH, Schuster L, Quinn C: Hypertonic saline resuscitation of head injury: Effects on cerebral water content. J Trauma 1990; 30:75-78
34. Hinson HE, Stein D, Sheth KN: Hypertonic saline and mannitol therapy in critical care neurology. J Intensive Care Med 2013; 28:3-11
35. Hijiya N, Horiuchi K, Asakura T: Morphology of sickle cells produced in solutions of varying osmolarities. J Lab Clin Med 1991; 117:60-66
36. Muizelaar JP, Wei E P, Kontos HA, et al: Mannitol causes compensatory cerebral vasoconstriction and vasodilation in response to blood viscosity changes. J Neurosurg 1983; 59:822-828
37. Qureshi AI, Suarez JI: Use of hypertonic saline solutions in treatment of cerebral edema and intracranial hypertension. Crit Care Med 2000; 28:3301-3313
38. Kempski O, Behmanesh S: Endothelial cell swelling and brain perfu-sion. J Trauma 1997; 42(5 Suppl):S38-S40
39. Nakayama S, Kramer GC, Carlsen RC, et al: Infusion of very hyper-tonic saline to bled rats: Membrane potentials and fuid shifts. J Surg Res 1985; 38:180-186
40. Gunnar W, Jonasson O, Merlotti G, et al: Head injury and hemorrhagic shock: Studies of the blood brain barrier and intracranial pressure after resuscitation with normal saline solution, 3% saline solution, and dextran-40. Surgery 1988; 103:398-407
41. Sorani MD, Manley GT: Dose-response relationship of mannitol and intracranial pressure: A metaanalysis. J Neurosurg 2008; 108:80-87
42. Khanna S, Davis D, Peterson B, et al: Use of hypertonic saline in the treatment of severe refractory posttraumatic intracranial hypertension in pediatric traumatic brain injury. Crit Care Med 2000; 28: 1144-1151
43. Vialet R, Albanèse J, Thomachot L, et al: Isovolume hypertonic solutes (sodium chloride or mannitol) in the treatment of refractory posttrau-matic intracranial hypertension: 2 mL/kg 7.5% saline is more effective than 2 mL/kg 20% mannitol. Crit Care Med 2003; 31:1683-1687
44. Battison C, Andrews PJ, Graham C, et al: Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline/6% dextran solution on increased intracranial pressure after brain injury. Crit Care Med 2005; 33:196-202
45. Oddo M, Levine JM, Frangos S, et al: Effect of mannitol and hyper-tonic saline on cerebral oxygenation in patients with severe traumatic brain injury and refractory intracranial hypertension. J Neurol Neuro-surg Psychiatr 2009; 80:916-920
46. Cooper DJ, Rosenfeld JV, Murray L, et al; DECRA Trial Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group: Decompressive craniectomy in diffuse traumatic brain injury. N Engl J Med 2011; 364:1493-1502
47. Marko NF: Hyperosmolar therapy for intracranial hypertension: Time to dispel antiquated myths. Am J Respir Crit Care Med 2012; 185:467-468